Fundz

Edity Therapeutics

Israel · Biotechnology, Health Care, Therapeutics

Edity Therapeutics is headquartered in Israel and is focused on the development of advanced immune cell delivery platforms, with product candidates across the fields of oncology, gene therapy, autoimmune disorders, and regenerative medicine. The company has been addressing the challenges of cell therapies for solid tumors, including antigen heterogeneity, the immunosuppressive tumor microenvironme

Key facts

Headquarters
Israel
Employees
841
Industries
Biotechnology, Health Care, Therapeutics
Status
Private
Website
edity-tx.com
LinkedIn
Company page

Recent activity at Edity Therapeutics

Edity Therapeutics in the news

Companies similar to Edity Therapeutics

About Edity Therapeutics: questions and answers

What does Edity Therapeutics do?

Edity Therapeutics is headquartered in Israel and is focused on the development of advanced immune cell delivery platforms, with product candidates across the fields of oncology, gene therapy, autoimmune disorders, and regenerative medicine. The company has been addressing the challenges of cell therapies for solid tumors, including antigen heterogeneity, the immunosuppressive tumor microenvironme

Where is Edity Therapeutics headquartered?

Edity Therapeutics is headquartered in Israel.

How many employees does Edity Therapeutics have?

Edity Therapeutics has about 841 employees.

What is the latest news on Edity Therapeutics?

On Apr 03, 2025, Edity Therapeutics and Aurigene Oncology Enter Strategic Co-Development Partnership for Novel Cell Therapy Program for Solid Tumors

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Edity Therapeutics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.